GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in GBP. All numbers in thousands
Revenue9/30/20179/30/20169/30/2015
Total Revenue11,05313,39943,231
Cost of Revenue4,7513,5323,966
Gross Profit6,3029,86739,266
Operating Expenses
Research Development149,231129,660116,311
Selling General and Administrative55,94625,90119,039
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-205,643-112,503-86,690
Income from Continuing Operations
Total Other Income/Expenses Net-4,60133,9819,765
Earnings Before Interest and Taxes-203,474-111,713-86,320
Interest Expense1,000225114
Income Before Tax-204,474-111,938-86,434
Income Tax Expense-27,795-29,247-18,931
Minority Interest---
Net Income From Continuing Ops-176,679-82,691-67,502
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-176,679-82,691-67,502
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-176,679-82,691-67,502